Last updated: 6 June 2024 at 7:45pm EST

Suzanne Crowe Net Worth




The estimated Net Worth of Suzanne Crowe is at least $39.4 millier dollars as of 20 September 2021. Suzanne Crowe owns over 1,066 units of AVITA Medical Inc stock worth over $39,352 and over the last 3 years Suzanne sold RCEL stock worth over $0.

Suzanne Crowe RCEL stock SEC Form 4 insiders trading

Suzanne has made over 1 trades of the AVITA Medical Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Suzanne bought 1,066 units of RCEL stock worth $18,207 on 20 September 2021.

The largest trade Suzanne's ever made was buying 1,066 units of AVITA Medical Inc stock on 20 September 2021 worth over $18,207. On average, Suzanne trades about 213 units every 0 days since 2021. As of 20 September 2021 Suzanne still owns at least 4,112 units of AVITA Medical Inc stock.

You can see the complete history of Suzanne Crowe stock trades at the bottom of the page.



What's Suzanne Crowe's mailing address?

Suzanne's mailing address filed with the SEC is C/O AVITA MEDICAL 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355.

Insiders trading at AVITA Medical Inc

Over the last 5 years, insiders at AVITA Medical Inc have traded over $2,850,472 worth of AVITA Medical Inc stock and bought 19,459 units worth $293,310 . The most active insiders traders include Michael S Perry, James Corbett et David D O'toole. On average, AVITA Medical Inc executives and independent directors trade stock every 82 days with the average trade being worth of $135,636. The most recent stock trade was executed by David D O'toole on 30 May 2024, trading 1,000 units of RCEL stock currently worth $8,900.



What does AVITA Medical Inc do?

avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.



Complete history of Suzanne Crowe stock trades at AVITA Medical Inc

Initié
Trans.
Transaction
Prix ​​total
Suzanne Crowe
Acheter $18,207
20 Sep 2021


AVITA Medical Inc executives and stock owners

AVITA Medical Inc executives and other stock owners filed with the SEC include: